Literature DB >> 30478004

Vaccine preventable invasive bacterial diseases in Italy: A comparison between the national surveillance system and recorded hospitalizations, 2007-2016.

Patrizio Pezzotti1, Stefania Bellino2, Flavia Riccardo2, Francesca Lucaroni3, Marina Cerquetti2, Annalisa Pantosti2, Giovanni Rezza2, Paola Stefanelli4.   

Abstract

BACKGROUND: Vaccine-preventable <span class="Disease">invasive bacterial diseases (IBDs) caused by Neisseria meningitidis (Nm), Streptococcus pneumoniae (Sp), and Haemophilus influenzae (Hi) have been notified in Italy since 2007 without assessing reporting completeness.
METHODS: Our study compared the number of cases of IBDs identified from the Italian Hospital Discharge Records (HDRs), using specific diagnostic ICD-9-CM codes, with those notified to the National Surveillance System (NSS) from 2007 to 2016. A multinomial logistic regression model was used to impute the aetiology of all discharges with a diagnosis of unspecified bacterial meningitis.
RESULTS: Over a 10-year period, 14,243 hospital discharges with diagnosis of IBD were estimated in Italy (12,671 with specified aetiology and 1,572 with imputed aetiology). Among those, 2,513 (17.6%) were caused by Nm, 10,441 (73.3%) by Sp, and 1289 (9.1%) by Hi. Most invasive meningococcal diseases were coded as meningitis (72.3%), while Hi and Sp were more frequently coded as septicaemia (51.6% and 60.4%, respectively). The highest mean annual incidence rate was found for IBD caused by Sp (1.74 per 100,000), followed by Nm (0.42 per 100,000) and by Hi (0.21 per 100,000). Comparing NSS with HDR data, we found an initially high underreporting of all IBDs, and particularly for Hi. Data from the two systems overlapped in more recent years, due to an improved reporting completeness. The increasing IBD incidence observed in NSS data was not confirmed by HDR data trends, although with pathogen-related differences with Hi cases rising in both data sources, suggesting that is mainly due to an improved disease notification rather than to a true incidence increase.
CONCLUSIONS: Comparing surveillance data with other data sources is useful to better interpret observed trends of notifiable diseases.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Haemophilus influenzae; Hospital discharge records; Invasive bacterial disease; National surveillance system; Neisseria meningitidis; Streptococcus pneumoniae

Mesh:

Year:  2018        PMID: 30478004     DOI: 10.1016/j.vaccine.2018.11.047

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Burden of pneumococcal disease among adults in Southern Europe (Spain, Portugal, Italy, and Greece): a systematic review and meta-analysis.

Authors:  Adoración Navarro-Torné; Eva Agostina Montuori; Vasiliki Kossyvaki; Cristina Méndez
Journal:  Hum Vaccin Immunother       Date:  2021-06-09       Impact factor: 4.526

2.  Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015-2018.

Authors:  Xanthi D Andrianou; Flavia Riccardo; Maria Grazia Caporali; Cecilia Fazio; Arianna Neri; Paola Vacca; Luigina Ambrosio; Patrizio Pezzotti; Paola Stefanelli
Journal:  PLoS One       Date:  2021-01-08       Impact factor: 3.240

3.  Laboratory-based surveillance in Latin America: attributes and limitations in evaluation of pneumococcal vaccine impact.

Authors:  Javier Nieto Guevara; Adriana Guzman-Holst
Journal:  Hum Vaccin Immunother       Date:  2021-10-07       Impact factor: 3.452

4.  The impact of COVID-19 pandemic control on vaccine-preventable invasive bacterial diseases in Piedmont (Italy).

Authors:  Marco Peradotto; A Bondi; D Lombardi; P Bottino; E Zanotto; A M Barbui; R Cavallo
Journal:  Infection       Date:  2022-02-16       Impact factor: 3.553

5.  Incidence of invasive pneumococcal disease in children with commercial insurance or Medicaid coverage in the United States before and after the introduction of 7- and 13-valent pneumococcal conjugate vaccines during 1998-2018.

Authors:  Tianyan Hu; Yan Song; Nicolae Done; Qing Liu; Eric M Sarpong; Esteban Lemus-Wirtz; James Signorovitch; Salini Mohanty; Thomas Weiss
Journal:  BMC Public Health       Date:  2022-09-05       Impact factor: 4.135

6.  Invasive meningococcal disease in Italy: from analysis of national data to an evidence-based vaccination strategy.

Authors:  S Igidbashian; L Bertizzolo; A Tognetto; C Azzari; P Bonanni; P Castiglia; M Conversano; S Esposito; G Gabutti; G Icardi; P L Lopalco; F Vitale; S Parisi; G Checcucci Lisi
Journal:  J Prev Med Hyg       Date:  2020-07-04

Review 7.  Preventing Infections by Encapsulated Bacteria Through Vaccine Prophylaxis in Inflammatory Bowel Disease.

Authors:  Marco Vincenzo Lenti; Caterina Mengoli; Marta Vernero; Nicola Aronico; Laura Conti; Federica Borrelli de Andreis; Sara Cococcia; Antonio Di Sabatino
Journal:  Front Immunol       Date:  2020-03-23       Impact factor: 7.561

8.  Invasive Pneumococcal Disease in Tuscany Region, Italy, 2016-2017: Integrating Multiple Data Sources to Investigate Underreporting.

Authors:  Filippo Quattrone; Gabriele Donzelli; Sara D'Arienzo; Marco Fornili; Francesco Innocenti; Silvia Forni; Laura Baglietto; Lara Tavoschi; Pier Luigi Lopalco
Journal:  Int J Environ Res Public Health       Date:  2020-10-19       Impact factor: 3.390

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.